General Information of Drug Off-Target (DOT) (ID: OT3U8FD0)

DOT Name ATP-dependent RNA helicase DDX1 (DDX1)
Synonyms EC 3.6.4.13; DEAD box protein 1; DEAD box protein retinoblastoma; DBP-RB
Gene Name DDX1
Related Disease
Atypical endometrial hyperplasia ( )
Breast cancer ( )
Breast carcinoma ( )
Colorectal carcinoma ( )
Drug dependence ( )
Gastroenteritis ( )
Neoplasm ( )
Neoplasm of testis ( )
Neuroblastoma ( )
Ovarian neoplasm ( )
Retinoblastoma ( )
Seminoma ( )
Substance abuse ( )
Substance dependence ( )
Wilms tumor ( )
Advanced cancer ( )
Asthma ( )
Bloom syndrome ( )
Chronic obstructive pulmonary disease ( )
Hepatocellular carcinoma ( )
UniProt ID
DDX1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
4XW3; 8TBX
EC Number
3.6.4.13
Pfam ID
PF00270 ; PF00271 ; PF00622
Sequence
MAAFSEMGVMPEIAQAVEEMDWLLPTDIQAESIPLILGGGDVLMAAETGSGKTGAFSIPV
IQIVYETLKDQQEGKKGKTTIKTGASVLNKWQMNPYDRGSAFAIGSDGLCCQSREVKEWH
GCRATKGLMKGKHYYEVSCHDQGLCRVGWSTMQASLDLGTDKFGFGFGGTGKKSHNKQFD
NYGEEFTMHDTIGCYLDIDKGHVKFSKNGKDLGLAFEIPPHMKNQALFPACVLKNAELKF
NFGEEEFKFPPKDGFVALSKAPDGYIVKSQHSGNAQVTQTKFLPNAPKALIVEPSRELAE
QTLNNIKQFKKYIDNPKLRELLIIGGVAARDQLSVLENGVDIVVGTPGRLDDLVSTGKLN
LSQVRFLVLDEADGLLSQGYSDFINRMHNQIPQVTSDGKRLQVIVCSATLHSFDVKKLSE
KIMHFPTWVDLKGEDSVPDTVHHVVVPVNPKTDRLWERLGKSHIRTDDVHAKDNTRPGAN
SPEMWSEAIKILKGEYAVRAIKEHKMDQAIIFCRTKIDCDNLEQYFIQQGGGPDKKGHQF
SCVCLHGDRKPHERKQNLERFKKGDVRFLICTDVAARGIDIHGVPYVINVTLPDEKQNYV
HRIGRVGRAERMGLAISLVATEKEKVWYHVCSSRGKGCYNTRLKEDGGCTIWYNEMQLLS
EIEEHLNCTISQVEPDIKVPVDEFDGKVTYGQKRAAGGGSYKGHVDILAPTVQELAALEK
EAQTSFLHLGYLPNQLFRTF
Function
Acts as an ATP-dependent RNA helicase, able to unwind both RNA-RNA and RNA-DNA duplexes. Possesses 5' single-stranded RNA overhang nuclease activity. Possesses ATPase activity on various RNA, but not DNA polynucleotides. May play a role in RNA clearance at DNA double-strand breaks (DSBs), thereby facilitating the template-guided repair of transcriptionally active regions of the genome. Together with RELA, acts as a coactivator to enhance NF-kappa-B-mediated transcriptional activation. Acts as a positive transcriptional regulator of cyclin CCND2 expression. Binds to the cyclin CCND2 promoter region. Associates with chromatin at the NF-kappa-B promoter region via association with RELA. Binds to poly(A) RNA. May be involved in 3'-end cleavage and polyadenylation of pre-mRNAs. Component of the tRNA-splicing ligase complex required to facilitate the enzymatic turnover of catalytic subunit RTCB: together with archease (ZBTB8OS), acts by facilitating the guanylylation of RTCB, a key intermediate step in tRNA ligation. Component of a multi-helicase-TICAM1 complex that acts as a cytoplasmic sensor of viral double-stranded RNA (dsRNA) and plays a role in the activation of a cascade of antiviral responses including the induction of pro-inflammatory cytokines via the adapter molecule TICAM1. Specifically binds (via helicase ATP-binding domain) on both short and long poly(I:C) dsRNA; (Microbial infection) Required for HIV-1 Rev function as well as for HIV-1 and coronavirus IBV replication. Binds to the RRE sequence of HIV-1 mRNAs; (Microbial infection) Required for Coronavirus IBV replication.
Tissue Specificity Highest levels of transcription in 2 retinoblastoma cell lines and in tissues of neuroectodermal origin including the retina, brain, and spinal cord.
Reactome Pathway
tRNA processing in the nucleus (R-HSA-6784531 )
BioCyc Pathway
MetaCyc:ENSG00000079785-MONOMER

Molecular Interaction Atlas (MIA) of This DOT

20 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Atypical endometrial hyperplasia DIS2POYG Strong Biomarker [1]
Breast cancer DIS7DPX1 Strong Genetic Variation [2]
Breast carcinoma DIS2UE88 Strong Genetic Variation [2]
Colorectal carcinoma DIS5PYL0 Strong Genetic Variation [3]
Drug dependence DIS9IXRC Strong Biomarker [4]
Gastroenteritis DISXQCG5 Strong Biomarker [5]
Neoplasm DISZKGEW Strong Biomarker [6]
Neoplasm of testis DISK4XHT Strong Biomarker [3]
Neuroblastoma DISVZBI4 Strong Altered Expression [2]
Ovarian neoplasm DISEAFTY Strong Biomarker [7]
Retinoblastoma DISVPNPB Strong Altered Expression [8]
Seminoma DIS3J8LJ Strong Altered Expression [9]
Substance abuse DIS327VW Strong Biomarker [4]
Substance dependence DISDRAAR Strong Biomarker [4]
Wilms tumor DISB6T16 Strong Biomarker [10]
Advanced cancer DISAT1Z9 moderate Biomarker [3]
Asthma DISW9QNS moderate Biomarker [11]
Bloom syndrome DISKXQ7J moderate Biomarker [12]
Chronic obstructive pulmonary disease DISQCIRF moderate Biomarker [11]
Hepatocellular carcinoma DIS0J828 Limited Biomarker [13]
------------------------------------------------------------------------------------
⏷ Show the Full List of 20 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
10 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin decreases the expression of ATP-dependent RNA helicase DDX1 (DDX1). [14]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of ATP-dependent RNA helicase DDX1 (DDX1). [15]
Arsenic trioxide DM61TA4 Approved Arsenic trioxide decreases the expression of ATP-dependent RNA helicase DDX1 (DDX1). [16]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide affects the expression of ATP-dependent RNA helicase DDX1 (DDX1). [17]
Menadione DMSJDTY Approved Menadione affects the expression of ATP-dependent RNA helicase DDX1 (DDX1). [17]
Ibuprofen DM8VCBE Approved Ibuprofen affects the expression of ATP-dependent RNA helicase DDX1 (DDX1). [18]
Bisphenol A DM2ZLD7 Investigative Bisphenol A increases the expression of ATP-dependent RNA helicase DDX1 (DDX1). [22]
Milchsaure DM462BT Investigative Milchsaure decreases the expression of ATP-dependent RNA helicase DDX1 (DDX1). [23]
GALLICACID DM6Y3A0 Investigative GALLICACID increases the expression of ATP-dependent RNA helicase DDX1 (DDX1). [24]
Okadaic acid DM47CO1 Investigative Okadaic acid increases the expression of ATP-dependent RNA helicase DDX1 (DDX1). [25]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Drug(s)
1 Drug(s) Affected the Protein Interaction/Cellular Processes of This DOT
Drug Name Drug ID Highest Status Interaction REF
DNCB DMDTVYC Phase 2 DNCB affects the binding of ATP-dependent RNA helicase DDX1 (DDX1). [19]
------------------------------------------------------------------------------------
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of ATP-dependent RNA helicase DDX1 (DDX1). [20]
TAK-243 DM4GKV2 Phase 1 TAK-243 increases the sumoylation of ATP-dependent RNA helicase DDX1 (DDX1). [21]
------------------------------------------------------------------------------------

References

1 Hormonally active doses of isoflavone aglycones promote mammary and endometrial carcinogenesis and alter the molecular tumor environment in Donryu rats.Toxicol Sci. 2012 Mar;126(1):39-51. doi: 10.1093/toxsci/kfs016. Epub 2012 Jan 16.
2 DEAD box 1 (DDX1) expression predicts for local control and overall survival in early stage, node-negative breast cancer.Cancer. 2012 Feb 15;118(4):888-98. doi: 10.1002/cncr.26352. Epub 2011 Jul 14.
3 DEAD box protein DDX1 promotes colorectal tumorigenesis through transcriptional activation of the LGR5 gene.Cancer Sci. 2018 Aug;109(8):2479-2489. doi: 10.1111/cas.13661. Epub 2018 Jul 17.
4 Genome wide association for addiction: replicated results and comparisons of two analytic approaches.PLoS One. 2010 Jan 21;5(1):e8832. doi: 10.1371/journal.pone.0008832.
5 Cellular RNA Helicase DDX1 Is Involved in Transmissible Gastroenteritis Virus nsp14-Induced Interferon-Beta Production.Front Immunol. 2017 Aug 9;8:940. doi: 10.3389/fimmu.2017.00940. eCollection 2017.
6 Epigenetic down-regulated DDX10 promotes cell proliferation through Akt/NF-B pathway in ovarian cancer.Biochem Biophys Res Commun. 2016 Jan 22;469(4):1000-5. doi: 10.1016/j.bbrc.2015.12.069. Epub 2015 Dec 20.
7 The RNA-binding protein DDX1 promotes primary microRNA maturation and inhibits ovarian tumor progression.Cell Rep. 2014 Sep 11;8(5):1447-60. doi: 10.1016/j.celrep.2014.07.058. Epub 2014 Aug 28.
8 Role of DEAD box 1 in retinoblastoma and neuroblastoma.Future Oncol. 2007 Oct;3(5):575-87. doi: 10.2217/14796694.3.5.575.
9 DDX1 is required for testicular tumorigenesis, partially through the transcriptional activation of 12p stem cell genes.Oncogene. 2009 May 28;28(21):2142-51. doi: 10.1038/onc.2009.89. Epub 2009 Apr 27.
10 Involvement of germline DDX1-MYCN duplication in inherited nephroblastoma.Eur J Med Genet. 2013 Dec;56(12):643-7. doi: 10.1016/j.ejmg.2013.10.004. Epub 2013 Oct 24.
11 Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis.Eur Respir J. 2014 Oct;44(4):860-72. doi: 10.1183/09031936.00001914. Epub 2014 Jul 3.
12 Role for RIF1-interacting partner DDX1 in BLM recruitment to DNA double-strand breaks.DNA Repair (Amst). 2017 Jul;55:47-63. doi: 10.1016/j.dnarep.2017.05.001. Epub 2017 May 13.
13 A Comprehensive Analysis of Argonaute-CLIP Data Identifies Novel, Conserved and Species-Specific Targets of miR-21 in Human Liver and Hepatocellular Carcinoma.Int J Mol Sci. 2018 Mar 14;19(3):851. doi: 10.3390/ijms19030851.
14 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
15 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
16 Proteomics-based identification of differentially abundant proteins from human keratinocytes exposed to arsenic trioxide. J Proteomics Bioinform. 2014 Jul;7(7):166-178.
17 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
18 Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC-MS/MS analysis: possible action of induced proteins on Alzheimer's disease. Proteomics. 2008 Apr;8(8):1595-607. doi: 10.1002/pmic.200700556.
19 Proteomic analysis of the cellular response to a potent sensitiser unveils the dynamics of haptenation in living cells. Toxicology. 2020 Dec 1;445:152603. doi: 10.1016/j.tox.2020.152603. Epub 2020 Sep 28.
20 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
21 Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. J Biol Chem. 2019 Oct 18;294(42):15218-15234. doi: 10.1074/jbc.RA119.009147. Epub 2019 Jul 8.
22 Bisphenol A Exposure Changes the Transcriptomic and Proteomic Dynamics of Human Retinoblastoma Y79 Cells. Genes (Basel). 2021 Feb 11;12(2):264. doi: 10.3390/genes12020264.
23 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
24 Gene expression profile analysis of gallic acid-induced cell death process. Sci Rep. 2021 Aug 18;11(1):16743. doi: 10.1038/s41598-021-96174-1.
25 Whole genome mRNA transcriptomics analysis reveals different modes of action of the diarrheic shellfish poisons okadaic acid and dinophysis toxin-1 versus azaspiracid-1 in Caco-2 cells. Toxicol In Vitro. 2018 Feb;46:102-112.